Human estrogen receptor ligand activity inversion mutants: Receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens

Molecular Endocrinology

Volumn 10, Issue 3, 1996, Pages 230-242

  Montano, Monica M ^a   Ekena, Kirk ^a   Krueger, Kristopher D ^a   Keller, Anne L ^a   Katzenellenbogen, Benita S ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; HYDROXYTAMOXIFEN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RU 54876; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; DRUG RECEPTOR BINDING; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR AFFINITY;

3T3 CELLS; ANIMALS; BREAST NEOPLASMS; CHO CELLS; CRICETINAE; CRICETULUS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HUMANS; LIGANDS; MICE; NEOPLASMS, HORMONE-DEPENDENT; POINT MUTATION; POLYUNSATURATED ALKAMIDES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; TAMOXIFEN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029978077     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.10.3.230     Document Type: Article

References (52)

1. Beato M 1989 Gene regulation by steroid hormones. Cell 56:335-344
2. Ham J, Parker MG 1989 Regulation of gene expression by nuclear hormone receptors. Curr Opin Cell Biol 1:503-511
3. Katzenellenbogen BS, Bhardwaj B, Fang H, Ince BA, Pakdel F, Reese JC, Schodin DJ, Wrenn CK 1993 Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems. J Steroid Biochem Mol Biol 47:39-48
4. Green S, Chambon P 1991 The oestrogen receptor: from perception to mechanism. In: Parker M (ed) Nuclear Hormone Receptors. Academic Press, New York, pp 15-38
5. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
6. Berry M, Metzger D, Chambon P 1990 Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818
7. Montano MM, Muller V, Trobaugh A, Katzenellenbogen BS 1995 The carboxy terminal F-domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol Endocrinol 9:814-825
8. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
9. Wakeling AE, Bowler J 1988 Biology and mode of action of pure antiestrogens. J Steroid Biochem 30:141-147
10. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873
11. Nique F, Van de Velde P, Bremaud J, Hardy M, Philibert D, Teutsch G 1994 11β-Amidoalkoxyphenyl estradiols, a new series of pure antiestrogens. J Steroid Biochem Mol Biol 50:21-29
12. Beekman JM, Allan GF, Tsai S, Tsai M, O'Malley BW 1993 Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol 7:1266-1274
13. Reese JC, Katzenellenbogen BS 1992 Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens. Mol Cell Biol 12:4531-4538
14. Sabbah M, Goiulleux F, Sola B, Redeuilh G, Baulieu E 1991 Structural differences between the hormone and antihormone estrogen receptor complexes bound to the hormone response element. Proc Natl Acad Sci USA 88:390-394
15. Metzger D, Berry M, Ali S, Chambon P 1995 Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol 9:579-581
16. Pham TA, Elliston JF, Nawaz Z, McDonnell DP, Tsai M, O'Malley 1991 Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers. Proc Natl Acad Sci USA 88:3125-3129
17. Brown M, Sharp P 1990 Human estrogen receptor forms multiple protein-DNA complexes. J Biol Chem 265: 11238-11243
18. Kumar V, Chambon P 1988 The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145-156
19. Reese JR, Katzenellenbogen BS 1991 Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. Nucleic Acids Res 19:6595-6602
20. Wrenn CK, Katzenellenbogen BS 1993 Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J Biol Chem 268: 24089-24098
21. Pakdel F, Katzenellenbogen, BS 1992 Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination. J Biol Chem 267:3429-3437
22. Pakdel F, Reese JC, Katzenellenbogen BS 1993 Identification of charged residues in an N-terminal portion of the hormone binding domain of the human estrogen receptor important in transcriptional activity of the receptor. Mol Endocrinol 7:1408-1417
23. Danielian PS, White R, Hoare SA, Fawell SE, Parker MG 1993 Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol 7:232-240
24. Ince BA, Zhuang Y, Wrenn CK, Shapiro DJ, Katzenellenbogen BS 1993 Powerful dominant negative mutants of the human estrogen receptor. J Biol Chem 268:14026-14032
25. Ince BA, Schodin DJ, Shapiro DJ, Katzenellenbogen BS 1995 Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors. Endocrinology 137:3194-3199
26. Jordan VC, Collins MM, Rowsby L, Prestwich G 1977 A monohydroxylated metabolite of tamoxifen with potent antiestrogenic activity. J Endocrinol 75:305-316
27. Arbuckle ND, Dauvois S, Parker MG 1992 Effects of antiestrogens on the DNA binding activity of estrogen receptors in vitro. Nucleic Acids Res 20:3839-3844
28. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
29. LeGoff P, Montano MM, Schodin DJ, Katzenellenbogen BS 1994 Phosphorylation of the human estrogen receptor: identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 269:4458-4466
30. Pakdel F, Le Guellec C, Vaillant C, Le Roux M, Valotaire Y 1989 Identification and estrogen induction of two estrogen receptor (ER) messenger ribonucleic acids in the rainbow trout liver: sequence homology with other ERs. Mol Endocrinol 3:44-51
31. Weiler IJ, Lew D, Shapiro DJ 1987 The Xenopus laevis estrogen receptor: sequence homology with human and avian receptor and identification of multiple estrogen receptor messenger ribonucleic acids. Mol Endocrinol 1:355-362
32. Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033
33. Dauvois S, Danielian PS, White R, Parker MG 1992 Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing turnover. Proc Natl Acad Sci USA 89:4037-4041
34. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW 1995 Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
35. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M 1994 Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458
36. Cavaillès V, Dauvois S, Danielian PS, Parker MG 1994 Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013
37. Landel CC, Kushner PJ, Greene GL 1994 The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol Endocrinol 8:1407-1419
38. Le Douarin B, Zechel C, Gamier J, Luyz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033
39. Mahfoudi A, Roulet E, Dauvois S, Parker MG, Wahli W 1995 Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc Natl Acad Sci USA 92:4206-4210
40. Lanz R, Rusconi S 1994 A conserved carboxy-terminal subdomain is important for ligand interpretation and transactivation by nuclear receptors. Endocrinology 135: 2183-2195
41. Vegeto E, Allan GF, Schrader WT, Tsai MJ, McDonnell DP, O'Malley BW 1992 The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69:703-713
42. Gottardis MM, Jordan VC 1988 Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res 48:5183-5187
43. Zimniski SJ, Warren RC 1993 Induction of tamoxifen-dependent rat mammary tumors. Cancer Res 53:2937-2939
44. Brunner N, Frandsen TL, Holst-Hansen C, Bei M, Thompson EW, Wakeling AE, Lippman ME, Clarke R 1993 MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI182,780. Cancer Res 53:3229-3232
45. Pakdel F, Le Goff P, Katzenellenbogen BS 1993 An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity. J Steroid Biochem Mol Biol 46:663-672
46. Mader S, Kumar V, de Verneuil H, Chambon P 1989 Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen-from a glucocorticoid-responsive element. Nature 338:271-274
47. Kunkel TA, Roberts JD, Zakour RA 1987 Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154:367-382
48. Aronica SM, Kraus WL, Katzenellenbogen BS 1994 Estrogen action via the cAMP signalling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521
49. Kraus WL, Montano MM, Katzenellenbogen BS 1993 Cloning of the rat progesterone receptor gene 5′region and identification of two functionally distinct promoters. Mol Endocrinol 7:1603-1616
50. Chang TC, Nardulli AM, Lew D, Shapiro DJ 1992 The role of estrogen response elements in the expression of the Xenopus laevis Vitellogenin B1 gene. Mol Endocrinol 6:346-354
51. Reese JC, Katzenellenbogen BS 1991 Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor: alterations in binding and transcriptional activation by covalently and reversibly attaching ligands. J Biol Chem 266:10880-10887
52. Ince BA, Montano MM, Katzenellenbogen BS 1994 Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′, 5′-monophosphate and ligands including antiestrogens. Mol Endocrinol 8:1397-1406